Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes

被引:289
|
作者
Stevens, LA
Djurdjev, O
Cardew, S
Cameron, EC
Levin, A
机构
[1] Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA
[2] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada
[3] Univ British Columbia, CHEOS, Vancouver, BC, Canada
[4] Univ British Columbia, Sch Med, Vancouver, BC, Canada
来源
关键词
D O I
10.1097/01.ASN.0000113243.24155.2F
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Current literature suggests associations between abnormal mineral metabolism (MM) to cardiovascular disease in dialysis populations, with conflicting results. MM physiology is complex; therefore, it was hypothesized that constellations of MM parameters, reflecting this complexity, would be predictive of mortality and that this effect would be modified by dialysis duration (DD). Prevalent dialysis patients in British Columbia, Canada, who had measurements of calcium (Ca), phosphate (Pi), and parathyroid hormone (iPTH) between January and March 2000 were followed prospectively until December 2002. Statistical analysis included Cox proportional hazard models with Ca, Pi, and iPTH alone and in combination as explanatory variables; analyses were stratified by DD. The 515 patients included in this analysis represent British Columbia and Canadian dialysis populations: 69% were on hemodialysis, mean age was 60 +/- 17 yr, 40% were female, and 34% had diabetes. Mean Ca and Pi values were 2.32 +/- 0.22 mmol/L and 1.68 +/- 0.59 mmol/L, respectively, and median iPTH was 15.8 pmol/L (25th to 75th percentile: 6.9 to 37.3 pmol/L). Serum Pi, after adjusting for demographic, dialysis type and adequacy, hemoglobin, and albumin, independently predicted mortality (risk ratio [RR], 1.56 per 1 mmol/L; 95% confidence interval [CI], 1.15 to 2.12; P = 0.004). When combinations of parameters were modeled (overall P = 0.003), the combinations of high serum Pi and Ca with high iPTH (RR, 3.7 1; 95% CI, 1.53 to 9.03; P = 0.004) and low iPTH (RR, 4.30; 95% CI, 2.01 to 9.22; P < 0.001) had highest risks for mortality as compared with the combination of high iPTH with normal serum Ca and Pi that had the lowest mortality and was used as index category. These effects varied across different strata of DD. This analysis demonstrates the importance of examining combinations of MM parameters as opposed to single variables alone and the effect of DD. In so doing, the complex interaction of time and MM can begin to be understand. Further exploration is required.
引用
收藏
页码:770 / 779
页数:10
相关论文
共 9 条
  • [1] Association Between Calcium, Phosphate, Intact Parathyroid Hormone Levels, and Mortality Among Patients on Peritoneal Dialysis
    Murashima, Miho
    Hamano, Takayuki
    Goto, Shunsuke
    Hasegawa, Takeshi
    Fukagawa, Masafumi
    Abe, Masanori
    Hanafusa, Norio
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 450 - 450
  • [2] Associations of calcium, phosphate and intact parathyroid hormone levels with mortality, residual kidney function and technical failure among patients on peritoneal dialysis
    Murashima, Miho
    Fujii, Naohiko
    Goto, Shunsuke
    Hasegawa, Takeshi
    Abe, Masanori
    Hanafusa, Norio
    Fukagawa, Masafumi
    Hamano, Takayuki
    CLINICAL KIDNEY JOURNAL, 2023, 16 (11) : 1957 - 1964
  • [3] Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism
    Oyama Y.
    Kazama J.J.
    Omori K.
    Higuchi N.
    Kameda S.
    Yamamoto S.
    Ito Y.
    Maruyama H.
    Narita I.
    Gejyo F.
    Clinical and Experimental Nephrology, 2005, 9 (2) : 142 - 147
  • [4] Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study
    Asada, Shinji
    Yokoyamaz, Keitaro
    Miyakoshi, Chisato
    Fukuma, Shingo
    Endo, Yuichi
    Wada, Michihito
    Nomura, Takanobu
    Onishi, Yoshihiro
    Fukagawa, Masafumi
    Fukuhara, Shunichi
    Akizawa, Tadao
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (07) : 630 - 637
  • [5] Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study
    Shinji Asada
    Keitaro Yokoyama
    Chisato Miyakoshi
    Shingo Fukuma
    Yuichi Endo
    Michihito Wada
    Takanobu Nomura
    Yoshihiro Onishi
    Masafumi Fukagawa
    Shunichi Fukuhara
    Tadao Akizawa
    Clinical and Experimental Nephrology, 2020, 24 : 630 - 637
  • [6] Association between the risk of death and serum calcium, phosphate, and intact parathyroid hormone levels in older patients undergoing maintenance hemodialysis: a cohort study in Beijing
    Li, Dishan
    Liu, Wenhu
    Huang, Hongdong
    Guo, Wang
    Diao, Zongli
    Chen, Xinpan
    Wangs, Weiwei
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [7] Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis
    Natoli, Jaime L.
    Boer, Rob
    Nathanson, Brian H.
    Miller, Ross M.
    Chiroli, Silvia
    Goodman, William G.
    Belozeroff, Vasily
    BMC NEPHROLOGY, 2013, 14
  • [8] Is there an association between elevated or low serum levels of phosphorus, parathyroid hormone, and calcium and mortality in patients with end stage renal disease? A meta-analysis
    Jaime L Natoli
    Rob Boer
    Brian H Nathanson
    Ross M Miller
    Silvia Chiroli
    William G Goodman
    Vasily Belozeroff
    BMC Nephrology, 14
  • [9] Correlation between Preoperative Serum Levels of Calcium, Phosphate, and Intact Parathyroid Hormone and Radiological Outcomes in Spinal Interbody Fusion among End-Stage Renal Disease Patients
    Shih, Ting-Yu
    Wu, Yun-Che
    Tseng, Sheng-Chieh
    Chen, Kun-Hui
    Pan, Chien-Chou
    Lee, Cheng-Hung
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)